Ischemic Heart Disease
Conditions
Keywords
ischemic heart disease, laugh therapy
Brief summary
Laugh is more than visual and vocal behave, is always followed by a series of physiological changes, including contractions of musculoskeletal system, increase of cardiac frequency by catecholamine release and hyperventilation that promoves the increase of maximum breathing and oxygen saturation. Laugh therapy may be an alternative therapy, simple, and improve the quality of life of individuals can influence physiological and biochemical parameters of the human body.
Detailed description
Methods: Randomized clinical trial with patients from outpatient ischemic heart disease of the Hospital de Clínicas de Porto Alegre , patients of both sexes in all regular monitoring. All patients will perform 30 minutes of stretching before film sessions. The exercises will be mild to moderate (modified Borg scale between 3 and 6).
Interventions
OTHERComedy
patients will watch comedy film
OTHERDocumentary
patients will watch a documentary film
Sponsors
Hospital de Clinicas de Porto Alegre
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* ischemic heart disease diagnosis established by cardiac catheterization, with 50% lesion in at least one epicardial vessel (if the patient has had an acute coronary syndrome or have been revascularized, the event time is expected to exceed 6 months). * Both sexes * With availability to come to HCPA twice a week * In conditions of entering into a cardiac rehabilitation program with exercise.
Exclusion criteria
* Involvement in another clinical trial. * Presence of autoimmune disease * Use of oral anticoagulant * Valvulopathy with mechanical or biological cardiac prosthesis * Presence pacemaker or implantable cardioverter * Left bundle branch block in 12-lead ECG * severe lung disease * Major Depression or Bipolar Disorder * Chronic Atrial Fibrillation * Left ventricular dysfunction (ejection fraction \<45%) * Active infection or cancer (other than basal cell carcinoma) * Chronic Renal Failure * Illiteracy * Inability to understand the consent form
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Cardiopulmonary exercise test | 48 months | The maximum functional capacity is measured by a maximal cardiopulmonary exercise test with expired gas analysis,in the treadmill Inbramed® KT 10200 (Porto Alegre, Brazil). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Quality of life Questionnaire | 48 months | SF-36 Questionnaire of life quality |
Countries
Brazil
Contacts
Primary ContactRosane M. Nery, PhD
Outcome results
None listed